Fargeot Pierre - Laboratoire de biologie médicale, centre Georges-François Leclerc

基本信息

浏览量：51

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 155 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase II Study of Carboplatin and Etoposide in Patients with Anaplastic Progressive Metastatic Castration-Resistant Prostate Cancer (mcrpc) with or Without Neuroendocrine Differentiation: Results of the French Genito-Urinary Tumor Group (GETUG) P01 Trial

A. Flechon,D. Pouessel,C. Ferlay,D. Perol,P. Beuzeboc,G. Gravis,F. Joly,S. Oudard,G. Deplanque,S. Zanetta,P. Fargeot,F. Priou,J. P. Droz,S. Culine

Annals of oncology（2011）

引用123浏览0WOS引用

123

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer ( mCRPC ) with or without neuroendocrine differentiation : results of the French GenitoUrinary Tumor Group ( GETUG ) P 01 trial

A. Flé Chon,D. Pouessel,C. Ferlay,D. Pérol,P. Beuzeboc,G. Gravis,F. Joly,S. Oudard,G. Deplanque,S. Zanetta,P. Fargeot,F. Priou,J. Droz, Culine, Le´on Be´rard, Lyon, Les Oudairies, L. Roche, Sur Yon

semanticscholar（2011）

引用72浏览0引用

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Rousseau F,Retornaz F, Joly F,Esterni B,Abadie-Lacourtoisie S,Fargeot P,Luporsi E,Servent V,Laguerre B,Brain E,Geneve J, Null Null

Critical Reviews in Oncology/Hematology（2010）

引用17浏览0WOS引用

[Germ Cell Testicular Tumors: Understanding the Kinetics of Serum Human Chorionic Gonadotropin During Chemotherapy]

J. -M. Riedinger,N. Eche,P. Fargeot

Annales de biologie clinique（2008）

引用2浏览0WOS引用

Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]

J-M Riedinger,N Eche,C Chevreau,P Fargeot

ANNALES DE BIOLOGIE CLINIQUE（2008）

引用1浏览0WOS引用

Pegfilgrastim Supports Delivery of FEC-100 Chemotherapy in Elderly Patients with High Risk Breast Cancer: A Randomized Phase 2 Trial

G. Romieu,M. Clemens,R. Mahlberg,P. Fargeot,M. Constenla, A. Schuette,V. Easton,T. Skacel,P. Bacon,W. Brugger

Critical reviews in oncology/hematology（2007）

引用34浏览0WOS引用

Prognostic Value of Change in CA 125 Levels after the First Cycle of Induction Chemotherapy for Epithelial Ovarian Cancers: Results of a Multicentric French Study

J. Riedinger,J. Basuyau,N. Eche,F. Bonnetain,M. F. Pichon,P. Fargeot

Journal of Clinical Oncologyno. 18_suppl (2007): 16017-16017

引用0浏览0引用

Pegase 03: a Prospective Randomized Phase III Trial of FEC with or Without High-Dose Thiotepa, Cyclophosphamide and Autologous Stem Cell Transplantation in First-Line Treatment of Metastatic Breast Cancer

P Biron,M Durand,H Roché,T Delozier,C Battista,P Fargeot,D Spaeth,T Bachelot, E Poiget, F Monnot,M L Tanguy,H Curé

Bone Marrow Transplantation（2007）

引用31浏览0WOSNATURE引用

Epirubicin-based Chemotherapy As Adjuvant Treatment for Poor Prognosis, Node-Negative Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 03 Trial

M Hery,S Schraub,J Bonneterre,H Roche,E Luporsi,P Kerbrat,P Fumoleau,A Monnier,P Fargeot,MJ Goudier,I Chapelle-Marcillac

Bulletin du cancerno. 10 (2006): E109-14

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn